TY - JOUR
TI - Cardiovascular events in chronic dialysis patients: emphasizing the
importance of vascular disease prevention
AU - Paraskevas, Kosmas I.
AU - Kotsikoris, Ioannis
AU - Koupidis, Sotirios A.
AU - and Tzovaras, Alexandros A.
AU - Mikhailidis, Dimitri P.
JO - International Urology and Nephrology
PY - 2010
VL - 42
TODO - 4
SP - 999-1006
PB - Springer-Verlag
SN - 0301-1623
TODO - 10.1007/s11255-010-9795-7
TODO - Hemodialysis; Peritoneal dialysis; Vascular disease prevention;
Mortality; Chronic kidney disease
TODO - Cardiovascular disease is the leading cause of death in both chronic
kidney disease and peritoneal dialysis/hemodialysis patients. Vascular
disease prevention in these patients is therefore important to reduce
the incidence of cardiovascular events and the high morbidity and
mortality. This Editorial discusses the traditional, (1) smoking, (2)
dyslipidemia, (3) body mass index, (4) glycemic control and (5) blood
pressure, and non-traditional, (1) anemia, (2) vitamin
D/hyperparathyroidism, (3) calcium/phosphorus metabolism and (4)
magnesium, risk factors in renal patients. Current evidence does not
support routine statin use and antiplatelet medication to dialysis
patients. Patient compliance and adherence to proposed measures could be
essential to reduce cardiovascular events and mortality rates in this
high-risk population.
ER -